BioMed Research International

BioMed Research International / 2017 / Article

Research Article | Open Access

Volume 2017 |Article ID 2984826 | 6 pages | https://doi.org/10.1155/2017/2984826

Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Obesity in Chinese Han Male College Students

Academic Editor: Hai-Feng Pan
Received28 Jun 2017
Revised06 Aug 2017
Accepted14 Aug 2017
Published18 Sep 2017

Abstract

Some reports have shown that nicotinamide N-methyltransferase (NNMT) is associated with the body mass index (BMI) and energy metabolism. Here we explored the association between NNMT gene polymorphisms and obesity. The subjects were recruited from male Chinese Han college student. 289 of them (19 ≤ body fat percentage (BF%)) were selected as the high body fat group (HBFG), 494 of them (3 ≤ BF% < 13.5) were selected as the low body fat group (LBFG), and then a case-control study (fat versus thin) was carried out to explore the association between the NNMT gene polymorphism and the body composition using tagSNPs method. A tagSNP (rs10891644) in NNMT gene was found significantly associated with the body composition (). At this locus, the BF% for the genotype GT, TT, and GG were , , and , respectively, and the differences between the GT and the GG + TT were highly significant (); the value of the GT versus (GG + TT) was 1.716 (, 95% CI = 1.240–2.235). Therefore, the variation of the tagSNP, rs10891644, is significantly associated with obesity and the GT carriers are the susceptible population.

1. Introduction

NNMT is an enzyme which catalyzes the methylation of nicotinamide (NAM) and produces methylnicotinamide (MNA) [1, 2]. Metabolomic works have showed that levels of MNA in urine were correlated with the body mass index (BMI) significantly [3, 4]; thus indicating that NNMT is involved in the regulation of the body fat. Recently, these findings have been supported by multiple evidences. For example, serum MNA was reportedly increased in Chinese obesity population [5] and urinary MNA was found elevated in humans with obesity and type 2 diabetes (T2D), in db/db mice and in obese Zucker rats [4]. These results implicate an increased NNMT activity in obesity. The more direct evidences came from Kraus et al. [6] and Lee et al. [7]. They found that Nnmt knockdown caused a 47% reduction in relative fat mass of mice [6], and NNMT expression is increased in adipocytes of obese population [7].

More than two hundreds of single nucleotide polymorphisms (SNPs) have been identified within human NNMT gene in recent years, and two noncoding region SNPs (rs694539 and rs1941404) have been reported to be significantly associated with some related noncommunicable chronic diseases (NCD), such as hyperhomocysteinemia [8], congenital heart diseases [9], abdominal aortic diseases [10], migraine [11], nonalcoholic steatohepatitis [12], bipolar disorder [13], epilepsy [14], schizophrenia [15], and hyperlipidemia [16]. However, the association between NNMT gene SNPs and the body composition has not yet been reported to date.

Are there any SNPs in NNMT DNA sequence significantly associated with obesity? We check all the candidate genetic association studies (CGASs) on NNMT gene and all the genome-wide association studies (GWASs) on obesity. The results show that no CGAS concerning NNMT gene and obesity has been carried out to date and that no SNP in NNMT DNA sequence has been identified to be significantly associated with obesity in existing GWASs. Theoretically, it is not surprising that NNMT gene is significantly associated with obesity. As the precursor of the NAD+, NAM methylation can directly affect NAD+ levels, because NAM cannot be used in the synthesis of NAD+ if it is methylated by NNMT [17]. NAD+ is essential for the fuel oxidation in our bodies. The competition between NNMT and NAD+ salvage suggests that NNMT gene polymorphisms might affect the fuel oxidation and the storage of fat. Then, why no SNP in NNMT gene has been identified to be significantly associated with obesity in GWASs?

In fact, GWASs usually apply strictest genome-wide significance criterion to overcome type I error which makes the false negative discoveries inevitable, therefore a CGAS is still necessary to check whether there are any NNMT SNPs significantly associated with the body composition. Moreover, the most existing GWASs used SNP data from HapMap Project, but many more SNPs have been sequenced in 1000 Genome Project nowadays, so it is possible that some significant SNPs in NNMT gene were not detected in GWASs.

To test this speculation, a tagSNP based CGAS was carried out in this investigation. Within a candidate gene, the number of SNPs may be large, but direct analysis of all SNPs is inefficient, because the genotypes at many of these loci are strongly correlated. It is a common method to select the maximally informative set of SNPs (tagSNPs) to analyze in a CGAS, thus all known SNPs either are directly assayed or highly associated with a tagSNP [18]. Here, we identified 19 tagSNPs (including rs694539 and rs1941404) across the whole NNMT gene DNA sequence using Haploview software (Haploview 4.2) in the first place and then performed a case-control (fat versus thin) study to explore the association between these tagSNPs and obesity.

2. Subjects and Methods

2.1. Subjects and Grouping

783 subjects were selected from Chinese Han male college students (aged from 17 to 23 years). According to their body fat percentage (BF%), the selected subjects were divided into two groups: the high body fat group (HBFG, 19 ≤ BF%, ) and the low body fat group (LBFG, 3 ≤ BF% < 13.5, ). The inclusion criteria were free of any diagnosed diseases (especially the anorexia, bulimia nervosa, and the diseases in the digestive system), without partiality for a particular kind of food and without exercise habit. The local ethics committee of Jiangxi Normal University approved this investigation, and the written informed consent was given to all the participants. This study conforms to the latest revision of the Declaration of Helsinki.

2.2. Body Component Measurement

Body component was measured using bioimpedance measurement with an X-SCAN PLUS body composition analyzer (X-SCAN PLUSII, Jawon Medical Co., Ltd., South Korea). Measurements were performed in the morning with empty stomachs.

2.3. SNP Selection and Genotyping

As mentioned above, there are many SNPs in NNMT gene. To determine the investigation of loci, a tagSNP approach was used [18]. With the criteria (MAF > 0.10 and ), nineteen tagSNPs were selected using Haploview software (Haploview 4.2) from the known SNP data in the Chinese Han population (CHB + CHS), which were downloaded from the database, 1000 Genomes Project (http://browser.1000genomes.org). Genomic DNA was extracted from blood samples with DNA extraction kits (Promega, USA). The gene sequence was downloaded from the database of National Center for Biotechnology Information (NCBI). Both probes and primers were designed with online software Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0). Genotypes of the SNPs were detected by polymerase chain reaction-ligase detection reaction (PCR-LDR) [17]. Ten percent of the PCR-LDR reactions were performed in duplicate to check the reliability of the genotyping, and more than 99.5% of them had the matching results. Additionally, Sanger sequencing method was used to genotype the significantly associated tagSNP (rs10891644) of 30 samples randomly selected, and 100% had the matching results with the PCR-LDR method.

2.4. Statistics

The frequency distributions of genotype and allele and Hardy–Weinberg equilibrium (HWE) were analyzed online (http://analysis.bio-x.cn). The HWE tests only performed in the control group. Four genetic models provided by Zintzaras and Santos [19] and two classification logistic regressions were used in the genotype effects analyses. The mean values were compared with one-way ANOVA with IBM SPSS Statistics 20.0 (SPSS Inc., Chicago, IL, USA). value < 0.05 was considered statistically significant. Bonferroni correction was performed for the analysis of the genotype and allele frequency distributions, and the corrected significance level was . The values and the odds ratios were adjusted for the age in the analysis of the genotype effects.

3. Results and Discussions

3.1. The Distributions of Alleles and Genotypes of the 19 Tag SNPs

The allele and genotype distributions of the 19 tagSNPs are shown in the Table 1. Among these SNPs, rs10891644 was the only one significantly associated SNP after Bonferroni correction () and qualified with HWE test (). At this locus, the HBLG exhibited a higher allele T frequency and a higher genotype GT frequency than the LBFG did. Thus the rs10891644 variation was focused in the rest analyses and the other SNPs were not analyzed any longer.


SNPsAllele frequencyGenotype frequencyHWE

rs2511153CaseC: 352 (0.63)T: 206 (0.37)0.708CC: 108 (0.39)CT: 57 (0.44)TT: 20 (0.16)0.827
Ctrl.C: 625 (0.64)T: 351 (0.36)CC: 199 (0.41)CT: 227 (0.47)TT: 62 (0.13)0.83
rs505978CaseA: 307 (0.54)C: 261 (0.46)0.668AA: 80 (0.28)AC: 254 (0.52)CC: 57 (0.20)0.909
Ctrl.A: 544 (0.55)C: 442 (0.45)AA: 145 (0.29)AC: 66 (0.50)CC: 94 (0.19)0.36
rs694539CaseA: 192 (0.34)G: 374 (0.66)0.613AA: 30 (0.11)AG: 132 (0.47)GG: 121 (0.43)0.861
Ctrl.A: 347 (0.35)G: 639 (0.65)AA: 55 (0.11)AG: 237 (0.48)GG: 201 (0.41)0.23
rs12285641CaseC: 349 (0.62)T: 217 (0.38)0.817CC: 102 (0.36)CT: 145 (0.51)TT: 36 (0.13)0.820
Ctrl.C: 585 (0.61)T: 373 (0.39)CC: 174 (0.36)CT: 237 (0.50)TT: 68 (0.14)0.38
rs11214926CaseA: 154 (0.27)G: 410 (0.73)0.871AA: 18 (0.06)AG: 118 (0.42)GG: 146 (0.52)0.810
Ctrl.A: 273 (0.28)G: 713 (0.72)AA: 28 (0.06)AG: 217 (0.44)GG: 248 (0.50)0.03
rs7109984CaseC: 502 (0.89)T: 64 (0.11)0.221CC: 224 (0.79)CT: 54 (0.19)TT: 5 (0.02)0.407
Ctrl.C: 829 (0.87)T: 129 (0.14)CC: 359 (0.75)CT: 111 (0.23)TT: 9 (0.02)0.90
rs10891644CaseG: 370 (0.64)T: 206 (0.36)GG: 111 (0.39)GT: 148 (0.51)TT: 29 (0.10)
Ctrl.G: 674 (0.70)T: 294 (0.30)GG: 243 (0.50)GT: 188 (0.39)TT: 53 (0.11)0.07
rs55675450CaseA: 88 (0.16)G: 470 (0.84)0.368AA: 5 (0.02)AG: 78 (0.28)GG: 196 (0.70)0.056
Ctrl.A: 138 (0.14)G: 842 (0.86)AA: 17 (0.04)AG: 104 (0.21)GG: 369 (0.75)0.01
rs2244175CaseA: 274 (0.48)G: 292 (0.52)0.147AA: 64 (0.23)AG: 146 (0.52)GG: 73 (0.26)0.337
Ctrl.A: 515 (0.52)G: 471 (0.48)AA: 132 (0.27)AG: 251 (0.51)GG: 110 (0.22)0.65
rs2847492CaseA: 198 (0.35)G: 368 (0.65)0.162AA: 33 (0.12)AG: 132 (0.47)GG: 118 (0.42)0.366
Ctrl.A: 380 (0.39)G: 606 (0.62)AA: 72 (0.15)AG: 236 (0.48)GG: 185 (0.38)0.82
rs2852432CaseC: 336 (0.59)T: 232 (0.41)0.209CC: 94 (0.33)CT: 148 (0.52)TT: 42 (0.15)0.286
Ctrl.C: 551 (0.56)T: 435 (0.44)CC: 153 (0.31)CT: 245 (0.50)TT: 95 (0.19)0.86
rs4646335CaseA: 326 (0.57)T: 242 (0.43)0.387AA: 89 (0.31)AT: 148 (0.52)TT: 47 (0.17)0.666
Ctrl.A: 588 (0.60)T: 398 (0.40)AA: 169 (0.34)AT: 250 (0.51)TT: 74 (0.15)0.24
rs3819100CaseA: 282 (0.50)G: 284 (0.50)0.597AA: 70 (0.25)AG: 142 (0.50)GG: 71 (0.25)0.825
Ctrl.A: 505 (0.51)G: 481 (0.49)AA: 126 (0.26)AG: 253 (0.51)GG: 114 (0.23)0.55
rs2256292CaseC: 234 (0.41)G: 338 (0.59)0.417CC: 50 (0.18)CG: 134 (0.47)GG: 102 (0.36)0.526
Ctrl.C: 382 (0.39)G: 602 (0.61)CC: 71 (0.14)CG: 240 (0.49)GG: 181 (0.37)0.55
rs2301128CaseA: 81 (0.15)G: 477 (0.86)0.071AA: 3 (0.01)AG: 75 (0.27)GG: 201 (0.72)0.051
Ctrl.A: 111 (0.11)G: 867 (0.89)AA: 8 (0.02)AG: 95 (0.19)GG: 386 (0.79)0.44
rs1941404CaseC: 265 (0.47)T: 301 (0.53)0.472CC: 59 (0.21)CT: 147 (0.52)TT: 77 (0.27)0.762
Ctrl.C: 443 (0.45)T: 543 (0.55)CC: 94 (0.19)CT: 255 (0.52)TT: 144 (0.29)0.32
rs2155806CaseC: 59 (0.11)T: 499 (0.89)0.200CC: 1 (0.00)CT: 57 (0.20)TT: 221 (0.79)0.387
Ctrl.C: 125 (0.13)T: 853 (0.87)CC: 4 (0.01)CT: 117 (0.24)TT: 368 (0.75)0.11
rs1941399CaseA: 102 (0.18)C: 464 (0.82)0.425AA: 4 (0.01)AC: 94 (0.33)CC: 185 (0.65)0.152
Ctrl.A: 194 (0.20)C: 792 (0.80)AA: 19 (0.04)AC: 156 (0.32)CC: 318 (0.65)0.98
rs4646337CaseA: 479 (0.86)G: 79 (0.14)0.935AA: 201 (0.72)AG: 77 (0.28)GG: 1 (0.00)0.102
Ctrl.A: 841 (0.86)G: 137 (0.14)AA: 362 (0.74)AG: 117 (0.24)GG: 10 (0.02)0.88

HWE, Hardy–Weinberg equilibrium; Case, the high body fat group; Ctrl., the low body fat group. HWE, value of Hardy–Weinberg equilibrium test on the control group; the values of allele and genotype are the number of individuals (frequency); ; .
3.2. Genotype Effects and Genetic Models of rs10891644 Variation

Genetic models (dominant, recessive, additive, and codominant) are often used in genotype effect analyses. However, these models are not totally independent. To avoid hash of these models, a whole solution and the degree of dominance () were offered by Zintzaras and Santos [19]. As shown in the Table 2, chances of subjects of the genotypes GG, GT, and TT to be the HBFG were 31%, 44%, and 35%, respectively. Two classification logistic regression analyses suggested that the dominant model and the codominance model were both significant () after the adjustment for age, and the adjusted degree of dominance () was less than −1 ( indicates that the phenotype of heterozygotes lies outside the phenotypical range of both homozygotes). Based on the values, these results indicate that the possible inheritance modes of the rs10891644 variation are dominant or codominant. However, the value of the additive model (GG versus TT) demonstrated that the difference between the homozygous GG and TT was not significant (), which denied the dominant mode, because in the dominant mode the difference between the homozygous genotypes must be significantly different. To determine whether the inheritance mode is overdominant, the value has been calculated, and the strongly suggests that the inheritance mode of the rs10891644 variation is overdominant. Overdominant inheritance is a condition in genetics where the phenotype of the heterozygote lies outside the phenotypical range of both homozygotes, which usually is described as heterosis, wherein heterozygous individuals have advantages in the natural selection. In this study, the value of the GT versus (GG + TT) was 1.716, which means that the chance of the GT being of HBFG is 1.716 times that of the homozygous (GG + TT), thus indicating that the heterozygous individuals (GT carriers) are the susceptible population to obesity. It is worth noting that although many diseases are associated with obesity nowadays, fat storage might be very helpful to enhance survival chances when lack of food in the long history of mankind. Therefore, it may be a result from the natural selection that the heterozygous individuals (GT carriers) are the susceptible population to obesity.


ModelGenotypeHBFGLBFGOR (95% CI)Adjusted
OR (95% CI)
() ()

RecessiveTT29 (0.35)53 (0.65)0.911
(0.564, 1.469)
0.932
(0.538, 1.614)
0.701 (0.802)2.83 (2.57)
(GT + GG)259 (0.38)431 (0.62)
Dominant(TT + GT)177 (0.42)241 (0.58)1.608
(1.195, 2.163)
1.669
(1.188, 2.345)
0.002
GG111 (0.31)243 (0.69)
AdditiveTT29 (0.35)53 (0.65)1.198
(0.723, 1.985)
1.239
(0.695, 2.208)
0.484 (0.468)
GG111 (0.31)243 (0.69)
CodominantGT148 (0.44)188 (0.56)1.664
(1.240, 2.235)
1.716
(1.220, 2.413)
0.001
(TT + GG)140 (0.32)296 (0.68)

HBFG, the high body fat group; LBFG, the low body fat group; the values of HBFG and LBFG are the number of individuals (ratio) from different genotypes; OR, odds ratio; CI, confidence interval; h (dominance degree) = , , OR of the codominant model, , OR of the additive model, indicates that the phenotype of the heterozygotes lies outside the phenotypical range of both homozygotes; Adjusted, adjustment for age. .

To further justify the genotype effects of the rs10891644 variation shown in Table 2, we compared the BF% between the subjects with different genotypes. As shown in Figure 1, the BF% of the GT, TT, and GG carriers were , , and , the highest was the GT carriers followed by the TT and the GG carriers, and there were highly significant differences () between the GT and the GG carriers, between the GT and the GG + TT carriers (codominant model), and between the GT + TT and the GG carriers (dominant model), respectively, while there were no significant differences between the GG and TT carriers (additive model) and between the TT and the GG + GT carriers (recessive model) (). These results further demonstrated that the body composition is significantly affected by the rs10891644 variation, and the inheritance mode of the rs10891644 variation is overdominant.

As mentioned above, although no NNMT gene SNP had been reported to be significantly associated with obesity before this paper, numerous reports have confirmed the roles of NNMT in regulation of the body composition. Among individuals, NNMT activity varies fivefold and has a bimodal frequency distribution in livers [20], but when the cDNAs of individuals with high and low NNMT activity were compared, no sequence differences were seen [21]. Thus the differences of phenotypes are due to the differences at transcriptional level and not because of NNMT SNPs in the coding regions [21]. NNMT gene is highly polymorphic in humans, and most of which are in the noncoding regions of this gene. The tagSNP (rs10891644), which was found significantly associated with obesity in this study, is also in the noncoding region (5′ near gene). Therefore, it presumably affects the transcription of NNMT gene, thus causing the genetic risk for fat storage.

The existing reports have shown that NMT plays roles in the regulation of energy metabolism [6, 22, 23] and the body composition [37]. Therefore it is reasonable that NNMT gene polymorphism is associated with obesity. However, besides the genetic factor, many other factors are also related to obesity, such as race, gender, age, diet, exercise, and the gut microbiome [2329]. To maximally eliminate the influences from other factors, we recruited the subjects from Chinese Han male college students, who were free of any diagnosed diseases (especially the anorexia, bulimia nervosa, and the diseases in the digestive system), without partiality for a particular kind of food and without exercise habit, and did the adjustment for age. The limitations of this investigation are that all participants were not entirely on the same controlled diet and that the influences of gut microbiome could not be eliminated.

In summary, for the first time we found that a tagSNP (rs10891644) in NNMT gene is significantly associated with obesity and the heterozygous individuals (GT carriers at this locus) are the susceptible population. Although the precise mechanism of the regulation process still needs further investigation, our findings suggest that the variant of a tagSNP (rs10891644) in NNMT gene is involved in the etiopathology of obesity in Chinese Han male college students.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

Authors’ Contributions

Qiong Zhou and Xiao-Juan Zhu contributed equally to this work.

Acknowledgments

This investigation was supported by the National Science Foundation of China (21365013) and by the Graduate Student Innovation Special Fund Project of Jiangxi Province (YC2016-S138).

References

  1. P. Pissios, “Nicotinamide N-methyltransferase: more than a vitamin B3 clearance enzyme,” Trends in Endocrinology and Metabolism, vol. 28, no. 5, pp. 340–353, 2017. View at: Publisher Site | Google Scholar
  2. J.-H. Li, W. Chen, X.-J. Zhu et al., “Associations of nicotinamide N-methyltransferase gene single nucleotide polymorphisms with sport performance and relative maximal oxygen uptake,” Journal of Sports Sciences, pp. 1–6, 2016. View at: Publisher Site | Google Scholar
  3. J. H. Li and Z. H. Wang, “Association between urinary low-molecular-weight metabolites and body mass index,” International Journal of Obesity, vol. 35, no. S2, 554 pages, 2011. View at: Google Scholar
  4. R. M. Salek, M. L. Maguire, E. Bentley et al., “A metabolomic comparison of urinary changes in type 2 diabetes in mouse, rat, and human,” Physiological Genomics, vol. 29, no. 2, pp. 99–108, 2007. View at: Publisher Site | Google Scholar
  5. M. Liu, L. Li, J. Chu et al., “Serum N1-methylnicotinamide is associated with obesity and diabetes in Chinese,” The Journal of Clinical Endocrinology & Metabolism, vol. 100, no. 8, pp. 3112–3117, 2015. View at: Publisher Site | Google Scholar
  6. D. Kraus, Q. Yang, D. Kong et al., “Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity,” Nature, vol. 508, no. 7495, pp. 258–262, 2014. View at: Publisher Site | Google Scholar
  7. Y. H. Lee, S. Nair, E. Rousseau et al., “Microarray profiling of isolated abdominal subcutaneous adipocytes from obese vs non-obese Pima Indians: Increased expression of inflammation-related genes,” Diabetologia, vol. 48, no. 9, pp. 1776–1783, 2005. View at: Publisher Site | Google Scholar
  8. J. C. Souto, F. Blanco-Vaca, J. M. Soria et al., “A genomewide exploration suggests a new candidate gene at chromosome 11q23 as the major determinant of plasma homocysteine levels: results from the GAIT project,” American Journal of Human Genetics, vol. 76, no. 6, pp. 925–933, 2005. View at: Publisher Site | Google Scholar
  9. L. M. J. W. van Driel, H. P. M. Smedts, W. A. Helbing et al., “Eight-fold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide,” European Heart Journal, vol. 29, no. 11, pp. 1424–1431, 2008. View at: Publisher Site | Google Scholar
  10. B. Giusti, C. Saracini, P. Bolli et al., “Genetic analysis of 56 polymorphisms in 17 genes involved in methionine metabolism in patients with abdominal aortic aneurysm,” Journal of Medical Genetics, vol. 45, no. 11, pp. 721–730, 2008. View at: Publisher Site | Google Scholar
  11. A. Sazci, G. Sazci, B. Sazci, E. Ergul, and H. A. Idrisoglu, “Nicotinamide-N-Methyltransferase gene rs694539 variant and migraine risk,” Journal of Headache and Pain, vol. 17, no. 1, article no. 93, 2016. View at: Publisher Site | Google Scholar
  12. A. Sazci, M. D. Ozel, E. Ergul, and C. Aygun, “Association of nicotinamide-N-methyltransferase gene rs694539 variant with patients with nonalcoholic steatohepatitis,” Genetic Testing and Molecular Biomarkers, vol. 17, no. 11, pp. 849–853, 2013. View at: Publisher Site | Google Scholar
  13. A. Sazci, M. D. Ozel, E. Ergul, and M. E. Onder, “Association of nicotinamide-N-methyltransferase (NNMT) gene rs694539 variant with bipolar disorder,” Gene, vol. 532, no. 2, pp. 272–275, 2013. View at: Publisher Site | Google Scholar
  14. G. Sazci, B. Sazci, A. Sazci, and H. A. Idrisoglu, “Association of nicotinamide-N-methyltransferase gene rs694539 variant with epilepsy,” Molecular Neurobiology, vol. 53, no. 6, pp. 4197–4200, 2016. View at: Publisher Site | Google Scholar
  15. A. Bromberg, E. Lerer, M. Udawela et al., “Nicotinamide-N-methyltransferase (NNMT) in schizophrenia: genetic association and decreased frontal cortex mRNA levels,” International Journal of Neuropsychopharmacology, vol. 15, no. 6, pp. 727–737, 2012. View at: Publisher Site | Google Scholar
  16. X.-J. Zhu, Y.-J. Lin, W. Chen et al., “Physiological study on association between nicotinamide N-methyltransferase gene polymorphisms and hyperlipidemia,” BioMed Research International, vol. 2016, Article ID 7521942, 2016. View at: Publisher Site | Google Scholar
  17. S. A. J. Trammell and C. Brenner, “NNMT: a bad actor in fat makes good in liver,” Cell Metabolism, vol. 22, no. 2, pp. 200-201, 2015. View at: Publisher Site | Google Scholar
  18. C. S. Carlson, M. A. Eberle, M. J. Rieder, Q. Yi, L. Kruglyak, and D. A. Nickerson, “Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium,” The American Journal of Human Genetics, vol. 74, no. 1, pp. 106–120, 2004. View at: Publisher Site | Google Scholar
  19. E. Zintzaras and M. Santos, “Estimating the mode of inheritance in genetic association studies of qualitative traits based on the degree of dominance index,” BMC Medical Research Methodology, vol. 11, article 171, 2011. View at: Publisher Site | Google Scholar
  20. J. Rini, C. Szumlanski, R. Guerciolini, and R. M. Weinshilboum, “Human liver nicotinamide N-methyltransferase: ion-pairing radiochemical assay, biochemical properties and individual variation,” Clinica Chimica Acta, vol. 186, no. 3, pp. 359–374, 1990. View at: Publisher Site | Google Scholar
  21. M.-L. Smith, D. Burnett, P. Bennett et al., “A direct correlation between nicotinamide N-methyltransferase activity and protein levels in human liver cytosol,” Biochimica et Biophysica Acta - Gene Structure and Expression, vol. 1442, no. 2-3, pp. 238–244, 1998. View at: Publisher Site | Google Scholar
  22. J.-H. Li, L.-Q. Qiu, X.-J. Zhu, and C.-X. Cai, “Influence of exercises using different energy metabolism systems on NNMT expression in different types of skeletal muscle fibers,” Science and Sports, vol. 32, no. 1, pp. 27–32, 2017. View at: Publisher Site | Google Scholar
  23. H. Tilg, “Obesity, metabolic syndrome and microbiota: multiple interactions,” Journal of Clinical Gastroenterology, vol. 44, supplement 1, pp. S16–S18, 2010. View at: Publisher Site | Google Scholar
  24. Y.-D. Gao, Y. Zhao, and J. Huang, “Metabolic modeling of common Escherichia coli strains in human gut microbiome,” BioMed Research International, vol. 2014, Article ID 694967, 11 pages, 2014. View at: Publisher Site | Google Scholar
  25. F. K. Videhult, I. Öhlund, H. Stenlund, O. Hernell, and C. E. West, “Probiotics during weaning: a follow-up study on effects on body composition and metabolic markers at school age,” European Journal of Nutrition, vol. 54, no. 3, pp. 355–363, 2016. View at: Publisher Site | Google Scholar
  26. A. Damms-Machado, S. Mitra, A. E. Schollenberger et al., “Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption,” BioMed Research International, vol. 2015, Article ID 806248, 12 pages, 2015. View at: Publisher Site | Google Scholar
  27. L. Wang, B. Zeng, X. Zhang et al., “The effect of green tea polyphenols on gut microbial diversity and fat deposition in C57BL/6J HFA mice,” Food and Function, vol. 7, no. 12, pp. 4956–4966, 2016. View at: Publisher Site | Google Scholar
  28. M. C. Dao, A. Everard, J. Aron-Wisnewsky et al., “Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology,” Gut, vol. 65, no. 3, pp. 426–436, 2016. View at: Publisher Site | Google Scholar
  29. A. C. Vaughn, E. M. Cooper, P. M. Dilorenzo et al., “Energy-dense diet triggers changes in gut microbiota, reorganization of gut-brain vagal communication and increases body fat accumulation,” Acta Neurobiologiae Experimentalis, vol. 77, no. 1, pp. 18–30, 2017. View at: Publisher Site | Google Scholar

Copyright © 2017 Qiong Zhou et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

910 Views | 258 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.